UroGen Pharma Ltd (URGN)
14.30
+0.04
(+0.28%)
USD |
NASDAQ |
May 03, 16:00
14.29
-0.01
(-0.07%)
After-Hours: 20:00
UroGen Pharma Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
March 30, 2022 | 24.44 |
March 29, 2022 | 25.97 |
March 28, 2022 | 24.22 |
March 25, 2022 | 23.20 |
March 24, 2022 | 23.41 |
March 23, 2022 | 22.39 |
March 22, 2022 | 23.82 |
March 21, 2022 | 24.30 |
March 18, 2022 | 24.28 |
March 17, 2022 | 24.49 |
March 16, 2022 | 23.74 |
March 15, 2022 | 22.71 |
March 14, 2022 | 22.63 |
March 11, 2022 | 23.36 |
March 10, 2022 | 24.47 |
March 09, 2022 | 23.01 |
March 08, 2022 | 20.67 |
March 07, 2022 | 16.76 |
March 04, 2022 | 16.27 |
March 03, 2022 | 16.30 |
March 02, 2022 | 16.36 |
March 01, 2022 | 16.00 |
February 28, 2022 | 16.17 |
February 25, 2022 | 16.17 |
February 24, 2022 | 15.95 |
Date | Value |
---|---|
February 23, 2022 | 16.06 |
February 22, 2022 | 16.00 |
February 18, 2022 | 16.39 |
February 17, 2022 | 17.46 |
February 16, 2022 | 18.48 |
February 15, 2022 | 19.09 |
February 14, 2022 | 18.50 |
February 11, 2022 | 18.88 |
February 10, 2022 | 19.92 |
February 09, 2022 | 20.96 |
February 08, 2022 | 20.11 |
February 07, 2022 | 20.43 |
February 04, 2022 | 19.57 |
February 03, 2022 | 18.93 |
February 02, 2022 | 19.65 |
February 01, 2022 | 20.80 |
January 31, 2022 | 20.61 |
January 28, 2022 | 19.44 |
January 27, 2022 | 18.96 |
January 26, 2022 | 20.85 |
January 25, 2022 | 21.39 |
January 24, 2022 | 21.41 |
January 21, 2022 | 20.32 |
January 20, 2022 | 20.91 |
January 19, 2022 | 19.95 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.605
Minimum
Mar 20 2020
25.98
Maximum
Jan 03 2022
5.941
Average
3.873
Median
Aug 31 2020
Price to Book Value Benchmarks
Agenus Inc | -- |
Exelixis Inc | 2.998 |
Geron Corp | 6.759 |
Protalix BioTherapeutics Inc | 2.481 |
InfuSystems Holdings Inc | 3.057 |
Price to Book Value Related Metrics
PS Ratio | 4.984 |
Price | 14.30 |
Earnings Yield | -25.66% |
Market Cap | 487.95M |